{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:31:35Z","timestamp":1791729095818,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.critrevonc.2017.10.013","type":"journal-article","created":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T03:16:21Z","timestamp":1509506181000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)"],"prefix":"10.1016","volume":"120","author":[{"given":"Ho-Shin","family":"Gwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0005","first-page":"1026","article-title":"Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group","volume":"33","author":"Albright","year":"1993","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3171\/2012.10.PEDS12142","article-title":"Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children","volume":"11","author":"Anderson","year":"2013","journal-title":"J. Neurosurg. Pediatr."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3171\/2011.3.JNS101381","article-title":"Effect of concentration on the accuracy of convective imaging distribution of a gadolinium-based surrogate tracer","volume":"115","author":"Asthagiri","year":"2011","journal-title":"J. Neurosurg."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.10.013_bib0020","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/neuonc\/nou091","article-title":"Phase 2 study of safety and efficacy of nimotuzumab in pediatric patients with progressive diffuse intrinsic pontine glioma","volume":"16","author":"Bartels","year":"2014","journal-title":"Neuro-Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.10.013_bib0025","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00701-013-1700-6","article-title":"Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma","volume":"155","author":"Barua","year":"2013","journal-title":"Acta Neurochir."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jneumeth.2013.02.007","article-title":"Intermittent convection-enhanced delivery to the brain through a novel transcutaneous bone-anchored port","volume":"214","author":"Barua","year":"2013","journal-title":"J. Neurosci. Methods"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0035","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1158\/0008-5472.CAN-09-2503","article-title":"Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma","volume":"70","author":"Becher","year":"2010","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.10.013_bib0040","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0045","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.91.6.2076","article-title":"Convection-enhanced delivery of macromolecules in the brain","volume":"91","author":"Bobo","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"June","key":"10.1016\/j.critrevonc.2017.10.013_bib0050","article-title":"Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents, American Society of Clinical Oncology","volume":"2007","author":"Bode","year":"2006","journal-title":"J. Clin. Oncol. (Meeting Abstracts)"},{"issue":"19","key":"10.1016\/j.critrevonc.2017.10.013_bib0055","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1002\/cncr.25405","article-title":"Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma","volume":"116","author":"Broniscer","year":"2010","journal-title":"Cancer"},{"issue":"31","key":"10.1016\/j.critrevonc.2017.10.013_bib0060","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1200\/JCO.2010.30.3545","article-title":"Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma","volume":"28","author":"Broniscer","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2017.10.013_bib0065","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1158\/1078-0432.CCR-13-0306","article-title":"Phase I trial, pharmacokinetics, and pharmacodynamics of vandetanib and dasatinib in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"19","author":"Broniscer","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0070","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1750-3639.2010.00468.x","article-title":"Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model","volume":"21","author":"Caretti","year":"2011","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3171\/jns.1999.90.2.0315","article-title":"Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time","volume":"90","author":"Chen","year":"1999","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0080","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0085","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00002371-200303000-00006","article-title":"Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer","volume":"26","author":"Crombet","year":"2003","journal-title":"J. Immunother."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0090","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0959-8049(02)00029-1","article-title":"Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d'Oncologie Pediatrique","volume":"38","author":"Doz","year":"2002","journal-title":"Eur. J. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.10.013_bib0095","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/cncr.23078","article-title":"A phase II study of the farnesyl transferase inhibitor, tipifarnib, in children with recurrent or progressive high-grade glioma, medulloblastoma\/primitive neuroectodermal tumor, or brainstem glioma: a Children's Oncology Group study","volume":"110","author":"Fouladi","year":"2007","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1215\/15228517-2008-029","article-title":"Preradiation chemotherapy may improve survival in pediatric diffuse intrinsic brainstem gliomas: final results of BSG 98 prospective trial","volume":"10","author":"Frappaz","year":"2008","journal-title":"Neuro-Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3171\/2008.11.PEDS08281","article-title":"Treatment of diffuse intrinsic brainstem gliomas: failed approaches and future strategies","volume":"3","author":"Frazier","year":"2009","journal-title":"J. Neurosurg. Pediatr."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(93)90228-N","article-title":"Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study","volume":"27","author":"Freeman","year":"1993","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.10.013_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ijc.23488","article-title":"EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts. International journal of cancer","volume":"123","author":"Geoerger","year":"2008","journal-title":"J. Int. Cancer"},{"issue":"13","key":"10.1016\/j.critrevonc.2017.10.013_bib0120","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.ejca.2009.03.007","article-title":"Target-driven exploratory study of imatinib mesylate in children with solid malignancies by the Innovative Therapies for Children with Cancer (ITCC) European Consortium","volume":"45","author":"Geoerger","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.10.013_bib0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/neuonc\/noq141","article-title":"Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing\/refractory brain tumors","volume":"13","author":"Geoerger","year":"2011","journal-title":"Neuro-Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2017.10.013_bib0130","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1016\/j.ejca.2010.07.005","article-title":"A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas","volume":"46","author":"Geyer","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"10 Pt 1","key":"10.1016\/j.critrevonc.2017.10.013_bib0135","first-page":"3620","article-title":"ERBB1 is amplified and overexpressed in high-grade diffusely infiltrative pediatric brain stem glioma","volume":"9","author":"Gilbertson","year":"2003","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0140","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0145","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/pbc.24060","article-title":"Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma","volume":"58","author":"Grill","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.10.013_bib0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/neuonc\/2.1.45","article-title":"The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery","volume":"2","author":"Groothuis","year":"2000","journal-title":"Neuro-Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2017.10.013_bib0155","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2009.26.8789","article-title":"Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study","volume":"28","author":"Gururangan","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1215\/15228517-2008-004","article-title":"Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma","volume":"10","author":"Haas-Kogan","year":"2008","journal-title":"Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/neuonc\/noq202","article-title":"Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas","volume":"13","author":"Haas-Kogan","year":"2011","journal-title":"Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0175","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3171\/2011.5.JNS11246","article-title":"Tracking accuracy of T2- and diffusion-weighted magnetic resonance imaging for infusate distribution by convection-enhanced delivery","volume":"115","author":"Iyer","year":"2011","journal-title":"J. Neurosurg."},{"issue":"12","key":"10.1016\/j.critrevonc.2017.10.013_bib0180","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00381-006-0174-8","article-title":"A novel brainstem tumor model: functional and histopathological characterization","volume":"22","author":"Jallo","year":"2006","journal-title":"Childs Nerv. Syst."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.10.013_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2011.06.007","article-title":"Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology","volume":"38","author":"Jansen","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"16","key":"10.1016\/j.critrevonc.2017.10.013_bib0190","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2002.04.109","article-title":"Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group","volume":"20","author":"Jennings","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/neuonc\/nos315","article-title":"Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas","volume":"15","author":"Kilburn","year":"2013","journal-title":"Neuro-Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2017.10.013_bib0205","first-page":"5143","article-title":"Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class","volume":"60","author":"Kilic","year":"2000","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.10.013_bib0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3171\/jns.2005.103.5.0923","article-title":"Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents","volume":"103","author":"Krauze","year":"2005","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0215","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/1097-0142(19930815)72:4<1404::AID-CNCR2820720441>3.0.CO;2-G","article-title":"Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833","volume":"72","author":"Kretschmar","year":"1993","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11060-012-0842-3","article-title":"Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas","volume":"108","author":"Li","year":"2012","journal-title":"J. Neurooncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3171\/jns.2004.100.3.0472","article-title":"Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I\/II clinical study","volume":"100","author":"Lidar","year":"2004","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.10.013_bib0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/JNS-07\/07\/0190","article-title":"Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note","volume":"107","author":"Lonser","year":"2007","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1517\/14712598.2011.546341","article-title":"Nimotuzumab for pediatric diffuse intrinsic pontine gliomas","volume":"11","author":"Massimino","year":"2011","journal-title":"Expert Opin. Biol. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0245","first-page":"305","article-title":"Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood","volume":"118","author":"Massimino","year":"2014","journal-title":"J. Neurooncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2017.10.013_bib0250","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1007\/s00280-011-1555-6","article-title":"Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy","volume":"67","author":"Masuda","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"9","key":"10.1016\/j.critrevonc.2017.10.013_bib0255","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/glia.20986","article-title":"Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation","volume":"58","author":"Masui","year":"2010","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.critrevonc.2017.10.013_bib0260","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neo.2015.12.002","article-title":"A novel mouse model of diffuse intrinsic pontine glioma initiated in pax3-expressing cells","volume":"18","author":"Misuraca","year":"2016","journal-title":"Neoplasia"},{"issue":"11","key":"10.1016\/j.critrevonc.2017.10.013_bib0265","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0270","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3171\/jns.2003.98.3.0584","article-title":"Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging","volume":"98","author":"Nguyen","year":"2003","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.critrevonc.2017.10.013_bib0275","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00381-009-1000-x","article-title":"Stereotactic biopsy for brainstem tumors in pediatric patients","volume":"26","author":"Perez-Gomez","year":"2010","journal-title":"Childs Nerv. Syst."},{"issue":"2 Suppl","key":"10.1016\/j.critrevonc.2017.10.013_bib0280","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3171\/ped.2006.104.2.7","article-title":"Brainstem stereotactic biopsy sampling in children","volume":"104","author":"Pincus","year":"2006","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1215\/15228517-2006-031","article-title":"Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report","volume":"9","author":"Pollack","year":"2007","journal-title":"Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0290","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/neuonc\/noq199","article-title":"A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium","volume":"13","author":"Pollack","year":"2011","journal-title":"Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0295","doi-asserted-by":"crossref","first-page":"e30313","DOI":"10.1371\/journal.pone.0030313","article-title":"Mesenchymal transition and PDGFRA amplification\/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas","volume":"7","author":"Puget","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.critrevonc.2017.10.013_bib0300","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1136\/jnnp.2009.174250","article-title":"Serial stereotactic biopsy of brainstem lesions in adults improves diagnostic accuracy compared with MRI only","volume":"80","author":"Rachinger","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4161\/cbt.5.4.2522","article-title":"Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I\/II tria","volume":"5","author":"Ramos","year":"2006","journal-title":"Cancer. Biol. Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0310","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clineuro.2012.04.027","article-title":"Bevacizumab as salvage therapy for progressive brain stem gliomas","volume":"115","author":"Reithmeier","year":"2013","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"1 Suppl","key":"10.1016\/j.critrevonc.2017.10.013_bib0315","first-page":"1","article-title":"Stereotactic biopsy of diffuse pontine lesions in children","volume":"107","author":"Roujeau","year":"2007","journal-title":"J. Neurosurg."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.10.013_bib0320","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3171\/2011.2.PEDS10407","article-title":"Regression of recurrent glioblastoma infiltrating the brainstem after convection-enhanced delivery of nimustine hydrochloride","volume":"7","author":"Saito","year":"2011","journal-title":"J. Neurosurg. Pediatr."},{"issue":"5","key":"10.1016\/j.critrevonc.2017.10.013_bib0325","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3171\/jns.2002.96.5.0885","article-title":"Convection-enhanced delivery into the rat brainstem","volume":"96","author":"Sandberg","year":"2002","journal-title":"J. Neurosurg."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0330","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1535-7163.MCT-06-0691","article-title":"Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel","volume":"6","author":"Sarkaria","year":"2007","journal-title":"Mol. Cancer Ther."},{"issue":"17","key":"10.1016\/j.critrevonc.2017.10.013_bib0335","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/jnci\/90.17.1269","article-title":"Trends in reported incidence of primary malignant brain tumors in children in the United States","volume":"90","author":"Smith","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.10.013_bib0340","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1177\/0883073808321064","article-title":"Convection-enhanced delivery for the treatment of pediatric neurologic disorders","volume":"23","author":"Song","year":"2008","journal-title":"J. Child Neurol."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0345","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/ije\/23.3.458","article-title":"International incidence of childhood brain and spinal tumours","volume":"23","author":"Stiller","year":"1994","journal-title":"Int. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.critrevonc.2017.10.013_bib0350","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2017.10.013_bib0355","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11060-015-1969-9","article-title":"Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma","volume":"126","author":"Subashi","year":"2016","journal-title":"J. Neurooncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0360","doi-asserted-by":"crossref","first-page":"E880","DOI":"10.1227\/01.NEU.0000298922.77921.F2","article-title":"Effects of drug efflux on convection-enhanced paclitaxel delivery to malignant gliomas: technical note","volume":"61","author":"Tanner","year":"2007","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0365","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0370","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00280-012-1929-4","article-title":"Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer","volume":"70","author":"Togashi","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.critrevonc.2017.10.013_bib0375","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.wneu.2016.02.040","article-title":"Application of convection-Enhanced drug delivery in the treatment of malignant gliomas","volume":"90","author":"Tykocki","year":"2016","journal-title":"World Neurosurg."},{"key":"10.1016\/j.critrevonc.2017.10.013_bib0380","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2015.00237","article-title":"DIPG in children \u2212 what can we learn from the past?","volume":"5","author":"Vanan","year":"2015","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2017.10.013_bib0385","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1158\/1078-0432.CCR-06-2309","article-title":"Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma","volume":"13","author":"Vredenburgh","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2017.10.013_bib0390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/neuonc\/nor190","article-title":"Genomic aberrations in pediatric diffuse intrinsic pontine gliomas","volume":"14","author":"Warren","year":"2012","journal-title":"Neuro-Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2017.10.013_bib0395","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J. Clin. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842817300653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T20:33:38Z","timestamp":1750970018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842817300653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":79,"alternative-id":["S1040842817300653"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.10.013","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2017.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}